The Actavis generic product is identical to Janssen's brand-name Concerta. FDA has not identified concerns with the Actavis or Janssen products.
Launch of Actavis' product is contingent upon Actavis receiving final Concerta (methylphenidate HCl) Extended-Release Tablets, (CII)
The One Authorized Concerta Generic: Watson/Actavis. There is only one authorized Concerta generic; the supplier is Watson/Actavis (old name/new
Although it is marketed by Actavis as a generic and not under the Concerta brand name, the Actavis drug is identical to Janssen s Concerta. This means that the data are insufficient to show
Effective, the Actavis (labeler ) authorized generic for Concerta (methylphenidate HCl) will be Brand name Concerta will remain
However, FDA found that Actavis, Janssen's generic equivalent for Concerta, is bioequivalent to, and substitutable for, Concerta. Related
Janssen manufactures an authorized generic of Concerta, which is marketed by Actavis under a licensing agreement. The Actavis product is not
bupivacaïne actavis (1) bupivacaïne actavis (1); byetta (1) byetta (1); bym338 concerta (1) concerta (1); cotellic (1) cotellic (1); coumadin (1)
Although it is marketed by Actavis as a generic and not under the Concerta brand name, the Actavis drug is identical to Janssen's Concerta.
Comments